Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Quality of Life and Treatment-related Side Effects of Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma

NCT04743999 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04743999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04743999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Quality of Life and Treatment-related Side Effects of Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Terminated
Start date
February 27, 2020
Completion date
June 27, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer